Bill > S03351

This bill adds tianeptine sodium to Schedule II of controlled substances in New York state's public health law. Tianeptine is a pharmaceutical substance originally developed as an antidepressant, but in recent years has gained notoriety for potential misuse and addiction potential, particularly when consumed in high doses. By placing it in Schedule II, the bill aims to regulate the substance more strictly, which typically means it will have recognized medical uses but also significant potential for abuse that can lead to severe psychological or physical dependence. The bill's provisions are straightforward, simply inserting "Tianeptine sodium" into the existing list of Schedule II controlled substances under the public health law. The legislation will take effect 90 days after it becomes law, providing a transition period for healthcare providers, pharmacies, and law enforcement to adjust to the new regulatory status of the substance.

Health and Social Services

https://www.nysenate.gov/legislation/bills/2025/S3351